Improving outcomes in donation after circulatory death vs. donation after brain death liver transplantation for acute-on-chronic liver failure
Transplant International · 21.08.2026 · 39
DOI: 10.3389/ti.2026.16308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 21.08.2026. Verfasst von Yvette Ysabel Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Liver Transplantation, Brain Death, Acute-On-Chronic Liver Failure, Tissue and Organ Procurement. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael Smith Health Research BC, Vancouver Coastal Health Research Institute, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Acute-on-chronic liver failure (ACLF) carries high short-term mortality, and liver transplantation (LT) remains the curative treatment. Donation after circulatory death (DCD) grafts expand the donor pool but carry higher risks of dysfunction compared to donation after brain death (DBD) grafts, and data directly comparing their outcomes in ACLF are limited. Using the Scientific Registry of Transplant Recipients (SRTR), we conducted a retrospective cohort study of 67,201 adult LT recipients from 2004 to 2023, stratified into three eras (Era 1: 2004–2012, Era 2: 2013–2018, Era 3: 2019–2023). Patients with prior LT, fulminant liver failure (status 1A), active hepatocellular carcinoma, or multivisceral transplants (excluding liver-kidney) were excluded. Estimated ACLF (EST-ACLF) severity was defined using EASL-CLIF criteria. One-year graft failure and survival were assessed using multivariable Cox regression and Kaplan-Meier analyses. Of 67,201 recipients, 62,510 received DBD and 4,691 DCD grafts. DCD grafts did not show clinically meaningful differences in 1-year hazards of graft failure compared to DBD grafts. One-year graft survival in EST-ACLF-2/3 improved over time from 87.2% in Era 1%–96.0% in Era 3, approaching the 97.5% observed with DBD grafts. DCD grafts may represent a viable and increasingly safe strategy for expanding LT access in ACLF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, The University of British Columbia, Vancouver, BC, Canada.
- Division of Gastroenterology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
Förderung
- Michael Smith Health Research BC
- Vancouver Coastal Health Research Institute
- Canadian Institutes of Health Research
- Canadian Donation and Transplantation Research Program
Zitieren
APA
Yao, Y. Y., Wen, T., Tjandra, N. W., Lau, K., Lin, Y. C., Chen, X., & Chahal, D. (2026). Improving outcomes in donation after circulatory death vs. donation after brain death liver transplantation for acute-on-chronic liver failure. Transplant International, 39. https://doi.org/10.3389/ti.2026.16308
Vancouver
Yao YY, Wen T, Tjandra NW, Lau K, Lin YC, Chen X, et al. Improving outcomes in donation after circulatory death vs. donation after brain death liver transplantation for acute-on-chronic liver failure. Transplant International. 2026;39. doi:10.3389/ti.2026.16308
BibTeX
@article{Yao2026,
author = {Yao, Yvette Ysabel and Wen, Tianyi and Tjandra, Nicholas Wellington and Lau, Kirby and Lin, Yi Chun and Chen, Xuan and Chahal, Daljeet},
title = {Improving outcomes in donation after circulatory death vs. donation after brain death liver transplantation for acute-on-chronic liver failure},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.16308}
}
EUVIMED